- Mutual Funds
- ICICI Prudential Mutual Fund
- ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Plan Growth
₹ 37.42
NAV (May 05)
Sectoral / Thematic - Pharma And Healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).
The pharma benchmark index itself has been a material underperformer over an extended time frame.
Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.
Scheme Information
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Expense Ratio | 1.94 % |
Launched 6Y ago | 2018-07-13 |
AUM in Crores | 4914.6 |
ISIN | INF109KC1GE9 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | - |
Standard Deviation | 16 |
Beta | 0.9 |
Sharpe Ratio | 0.9 |
YTM | - |
Asset allocation and Holdings
Top Stock Holdings
Sun Pharmaceutical Industries Ltd.
15.28%Dr. Reddy's Laboratories Ltd.
6.82%Cipla Ltd.
6.75%Aurobindo Pharma Ltd.
5.44%Others
4.79%
Allocation by Sector
Healthcare
89.02%Chemicals
5.77%Insurance
2.82%Services
1.43%
Comparison with Equity Funds
| Fund Name | Fund Size | |
|---|---|---|
₹ 23,379 cr | ||
₹ 64,962 cr | ||
₹ 49,131 cr | ||
₹ 27,730 cr | ||
₹ 16,217 cr |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Plan Growth Review
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Plan Growth is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 21.24% over 6 years. The fund has grown over a period of 6 years. The fund is managed by ICICI Prudential Mutual Fund. The fund managers are Dharmesh Kakkad, Sharmila D'mello.
Nav of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund as of 5/5/2025 is ₹37.42 with the total AUM as of 5/6/2025 is ₹4914.64. With Scripbox you can compare and check the latest nav for all mutual funds in India. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund was launched on 2018-07-13. The category risk of the fund is Very High.
The minimum SIP amount for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Plan Growth is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare Total Return Index.
Scripbox has rated it 3 stars, indicating it's a neutral fund in the Equity category and delivered 20.6% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund.